CompoAtlas

Hunter-Catalyst

Hunter-Catalyst, licence 80050321: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
North American Pharmacal, Inc.
NPN or DIN-HM
80050321
Status
Inactive licence
Licence date
22 April 2014
Revision date
Not provided
Form
Capsule végétale
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vaccinium myrtillus

Source : Fruit

7.5 mgNot calculated
Prunus serotina

Source : Fruit

7.5 mgNot calculated
Bifidobacterium bifidum

Source : ATCC SD5870

1.667 Millions d'UFCNot calculated
Camellia sinensis

Source : leaf standardized extract

Extraction ratio : 27:1

Dry plant equivalent : 1012.5 mg

Potency : 50.0 % polyphenols

37.5 mgNot calculated
Camellia sinensis

Source : leaf standardized extract

Potency : 3.75 mg caffeine

Not specifiedNot calculated
Camellia sinensis

Source : leaf standardized extract

Potency : 13.125 mg catechins

Not specifiedNot calculated
Allium sativum

Source : Bulbe

30.0 mgNot calculated

Non-medicinal ingredients

Silice, Trisilicate de magnésium, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Vcapsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of antioxidants to reduce oxidative stress/damage for the maintenance of good health. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80050321

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line